Bioscience Segment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bioscience segment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bioscience Segment Today - Breaking & Trending Today

Kepler Capital Sticks to Their Buy Rating for Grifols SA (GRFS)

In a report released on July 27, Pablo de Renteria from Kepler Capital maintained a Buy rating on Grifols SA (GRFS – Research Report), wi. ....

Comunidad Autonoma De Cataluna , Antonio Grifols Roig , Pablo De Renteria , Kepler Capital , Research Report , Moderate Buy , Bio Supplies , Bioscience Segment , Hospital Segment , Diagnostic Segment ,

Grifols, S.A. (NASDAQ:GRFS) Receives $13.53 Average Price Target from Analysts

Grifols, S.A. (NASDAQ:GRFS – Get Rating) has been given an average rating of “Moderate Buy” by the nine ratings firms that are presently covering the firm, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year target […] ....

Morgan Stanley , Fred Alger Management , Susquehanna International Securities Ltd , Mercer Global Advisors Inc , Grifols Company Profile , Geode Capital Management , Get Rating , Global Advisors , International Securities , Street Corp , Alger Management , Capital Management , Bio Supplies , Bioscience Segment , Hospital Segment , Grifols Daily ,

Grifols (NASDAQ:GRFS) Trading Down 2%

Shares of Grifols, S.A. (NASDAQ:GRFS – Get Rating) were down 2% during mid-day trading on Tuesday . The stock traded as low as $8.54 and last traded at $8.64. Approximately 98,387 shares were traded during mid-day trading, a decline of 89% from the average daily volume of 899,347 shares. The stock had previously closed at […] ....

Alanb Lancz Associates Inc , Grifols Company Profile , Gabelli Funds , Morgan Stanley , Hennion Walsh Asset Management Inc , Get Rating , Walsh Asset Management , Bio Supplies , Bioscience Segment , Hospital Segment , Grifols Daily , Nasdaq Grfs ,

Grifols (NASDAQ:GRFS) Shares Gap Up to $8.61

Grifols, S.A. (NASDAQ:GRFS – Get Rating) shares gapped up prior to trading on Wednesday . The stock had previously closed at $8.61, but opened at $9.20. Grifols shares last traded at $9.10, with a volume of 516,956 shares traded. Wall Street Analysts Forecast Growth Several research firms have commented on GRFS. Barclays raised shares of […] ....

Morgan Stanley , Advisor Group Holdings Inc , Quadrant Capital Group , Get Rating , Financial Advisors , Group Holdings , Capital Group , Bio Supplies , Bioscience Segment , Hospital Segment , Grifols Daily ,

Harris Associates L P Has $21.89 Million Holdings in Grifols, S.A. (NASDAQ:GRFS)

Harris Associates L P increased its stake in Grifols, S.A. (NASDAQ:GRFS – Get Rating) by 47.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,575,400 shares of the biotechnology company’s stock after purchasing an additional 832,800 shares during the period. Harris […] ....

Gabelli Funds , Morgan Stanley , Hennion Walsh Asset Management Inc , Harris Associates , Alanb Lancz Associates Inc , Exchange Commission , Get Rating , Walsh Asset Management , Bio Supplies , Bioscience Segment , Hospital Segment , Visit Holdingschannel , Grifols Daily ,